Eli Lilly drug slows Alzheimer’s disease progression: Study | Elizabeth Vargas Reports

An experimental Alzheimer’s treatment developed by Eli Lilly significantly slowed the progression of the disease, according to clinical trial data released Wednesday by the company. Dr. Robert Vassar, director of the Alzheimer's Disease Research Center at Northwestern University, discusses the drug on "Elizabeth Vargas Reports."
More #VargasReports: https://www.newsnationnow.com/joinus

Anchor Elizabeth Vargas delivers the biggest stories, without bias or opinion. Watch "Elizabeth Vargas Reports" every weeknight at 6p/5C on NewsNation. #VargasReports

NewsNation is your source for fact-based, unbiased news for all America.

More from NewsNation: https://www.newsnationnow.com/
Get our app: https://trib.al/TBXgYpp
Find us on cable: https://trib.al/YDOpGyG
How to watch on TV or streaming: https://trib.al/Vu0Ikij